Latest Breaking News On - Maarten meulenbelt - Page 1 : comparemela.com

With pharmaceutical regulation currently under review across Europe, Maarten Meulenbelt, Partner at Sidley Austin LLP, discusses some of the more controversial amendments under consideration.

United kingdomBruxelles capitaleCity ofNoord hollandThe councilHannah balfourMaarten meulenbeltDolon ltdSidley austinEu pharmaceuticals strategyEuropean parliamentEuropean commissionOffice of health economicsEuropean federation of pharmaceutical industry associationsPartner at sidley austinUnited kingdom office of health economics